FDA Inspection
Tubilux Pharma SpaTubilux Pharma Spa – FDA Inspection, Apr 6, 2018
Record Details
This FDA Inspection record concerns Tubilux Pharma Spa, with an inspection on April 6, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6c2d27fc-317a-46ad-85a4-fd3fed10264b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1047718
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.166(a)Lack of written stability program
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tubilux Pharma Spa
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 14, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 10, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 9, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Tubilux Pharma Spa
- FDA Inspection 1263915 - 2024-06-14
- FDA Inspection 1115090 - 2019-12-10
- FDA Inspection 998341 - 2016-12-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.